Clinical Trials

34 enrolled 15 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT04588545 2026-02-09

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Phase 1/2 Active not recruiting

39 enrolled

CNS

Meningeal Neoplasms, Meningeal Carcinomatosis

NCT03368729 2026-01-23

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

46 enrolled

Breast Neoplasms

NCT05256745 2025-12-24

RAGE

48 enrolled

Phase 1/2 Not yet recruiting

Cancer Related Cognitive Decline

NCT07136428 2025-12-19

ASCENdANT

42 enrolled

HER2+ Metastatic Breast Cancer

NCT01373710 2025-11-24

HIT

Phase 1/2 Not yet recruiting

34 enrolled

BreastCNS

Breast Neoplasms, Meningeal Carcinomatosis

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

36 enrolled

BreastOther solid neoplasm

HER2+ Advanced Breast Cancer

NCT03304080 2025-07-18

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Phase 1/2 Active not recruiting

44 enrolled

Breast Diseases, Breast Neoplasms

NCT05319873 2025-05-13

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

18 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT05640830 2024-11-26

TREAZURE

47 enrolled

HER2-positive Advanced Gastric Cancer

NCT06650332 2024-10-21

Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients

90 enrolled

Metastatic HER2 Positive Gastroesophageal Junction Cancer

NCT05574881 2024-02-26

Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

72 enrolled

Breast Neoplasms

NCT02066532 2023-08-24

Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer

32 enrolled 13 charts

Breast Neoplasms

NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

51 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01922921 2023-04-18

Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

31 enrolled 8 charts

Breast Neoplasms

NCT01306942 2023-03-30

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

37 enrolled 30 charts

Breast Neoplasms

NCT00129896 2023-03-06

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

73 enrolled

Breast Neoplasms

NCT04512261 2022-07-01

TOPAZ

BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases

NCT03913234 2022-05-10

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

95 enrolled

Breast Neoplasms

NCT04888663 2021-05-21

Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)

50 enrolled

Stomach Neoplasms

NCT04750122 2021-04-01

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

46 enrolled

HER2-positive Early Breast Cancer

NCT02139358 2021-02-04

Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer

15 enrolled 12 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

55 enrolled 10 charts

Breast Neoplasms

NCT00033514 2020-10-08

Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression

27 enrolled 12 charts

Breast Neoplasms

NCT02120911 2020-07-01

TRAP

40 enrolled

Esophageal Neoplasms

NCT03994107 2020-01-22

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

40 enrolled

Breast Neoplasms

NCT04152057 2019-11-05

Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

20 enrolled

Breast Neoplasms

NCT02318901 2019-10-21

PembroMab

16 enrolled 6 charts

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01325207 2019-09-26

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer

34 enrolled 14 charts

Breast Neoplasms

NCT02843126 2019-09-12

Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer

30 enrolled

Breast Neoplasms

NCT00923299 2019-04-16

THERAPY

33 enrolled

Pancreatic Neoplasms

NCT02297230 2018-10-15

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

44 enrolled 6 charts

Breast Neoplasms

NCT00006123 2018-05-16

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Breast Neoplasms

NCT02379585 2018-04-24

STEFNE

8 enrolled 1 chart

HER2-positive Breast Cancer

NCT02345772 2018-02-20

Neohttp

4 enrolled 1 chart

HER2-positive Breast Cancer

NCT00331552 2017-07-26

Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer

30 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00041470 2017-07-17

Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial

38 enrolled 6 charts

Breast Neoplasms

NCT00397501 2017-04-21

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00086957 2017-02-27

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

31 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01479179 2016-10-26

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Breast Neoplasms

NCT00458237 2016-10-20

Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer

11 enrolled 8 charts

Breast Neoplasms

NCT02030561 2016-06-22

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

29 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT02805829 2016-06-22

Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer

20 enrolled

Stomach Neoplasms

NCT00216047 2015-12-09

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

7 enrolled

Breast Neoplasms

NCT00095706 2015-09-25

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

50 enrolled

Breast Neoplasms

NCT01388647 2015-08-28

Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer

12 enrolled 12 charts

HER-2 Positive Breast Cancer

NCT00726180 2013-10-15

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

1 enrolled 4 charts

Breast Neoplasms

NCT00004925 2013-06-19

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00006108 2012-02-07

Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer